Amgen (NASDAQ:AMGN) has acquired Astellas Pharma’s (OTCPK:ALPMF) 49% share of Amgen Astellas BioPharma K.K., their joint venture in Japan established in 2013, for an undisclosed sum.
The business is now a wholly subsidiary of Amgen and has been renamed Amgen K.K.
https://seekingalpha.com/news/3557094-amgen-buys-astellas-share-of-japan-jv
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.